These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 20726330

  • 21. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X, Ren L, Sun G, Yu T, Yao Y, Wang L, Liu F, Zhang L, He X, Liu M.
    Immun Inflamm Dis; 2021 Jun 13; 9(2):407-418. PubMed ID: 33470559
    [Abstract] [Full Text] [Related]

  • 24. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
    Tsanyan ME, Torgashina AV, Aleksandrova EN, Soloviev SK, Nasonov EL.
    Ter Arkh; 2013 Jun 13; 85(5):53-9. PubMed ID: 23819340
    [Abstract] [Full Text] [Related]

  • 25. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus.
    Sjöwall C, Bentow C, Aure MA, Mahler M.
    J Immunol Res; 2018 Jun 13; 2018():1294680. PubMed ID: 30246032
    [Abstract] [Full Text] [Related]

  • 26. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 27. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun 02; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 28. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
    Yin Y, Wu X, Shan G, Zhang X.
    Lupus; 2012 Sep 02; 21(10):1088-97. PubMed ID: 22777943
    [Abstract] [Full Text] [Related]

  • 29. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 02; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 30. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.
    Rheumatol Int; 2013 May 02; 33(5):1193-9. PubMed ID: 22971892
    [Abstract] [Full Text] [Related]

  • 31. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA.
    Ann Rheum Dis; 2009 Feb 02; 68(2):234-7. PubMed ID: 18718989
    [Abstract] [Full Text] [Related]

  • 32. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH.
    Lupus; 2012 Jan 02; 21(1):36-42. PubMed ID: 21993384
    [Abstract] [Full Text] [Related]

  • 33. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
    Yang XW, Tan Y, Yu F, Zhao MH.
    Nephrol Dial Transplant; 2012 Sep 02; 27(9):3552-9. PubMed ID: 22700716
    [Abstract] [Full Text] [Related]

  • 34. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC, Zhou QL, Li XZ, Yang JH, Ao X, Veeraragoo P, Zuo XX.
    Cytokine; 2011 Mar 02; 53(3):295-300. PubMed ID: 21163672
    [Abstract] [Full Text] [Related]

  • 35. [Correlation of anti-C1q antibodies with active systemic lupus erythematosus and lupus nephritis in children].
    Li YZ, Yang JR, Zhang YD, Cao Y, Li XY, Shuai LJ, Wang Y, Shen T, Wu XC.
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug 15; 26(8):835-839. PubMed ID: 39148388
    [Abstract] [Full Text] [Related]

  • 36. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC, Wang CR, Liu MF, Chen FF, Liang CC.
    Asian Pac J Allergy Immunol; 2002 Dec 15; 20(4):223-7. PubMed ID: 12744622
    [Abstract] [Full Text] [Related]

  • 37. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C.
    Arthritis Care Res (Hoboken); 2018 Aug 15; 70(8):1263-1268. PubMed ID: 29045037
    [Abstract] [Full Text] [Related]

  • 38. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients.
    Jesus AA, Campos LM, Liphaus BL, Carneiro-Sampaio M, Mangueira CL, Rosseto EA, Silva CA, Scheinberg M.
    Rev Bras Reumatol; 2012 Dec 15; 52(6):976-81. PubMed ID: 23223707
    [Abstract] [Full Text] [Related]

  • 39. The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy.
    Moroni G, Quaglini S, Radice A, Trezzi B, Raffiotta F, Messa P, Sinico RA.
    J Immunol Res; 2015 Dec 15; 2015():106904. PubMed ID: 25815344
    [Abstract] [Full Text] [Related]

  • 40. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
    Gargiulo MLÁ, Khoury M, Gómez G, Grimaudo S, Suárez L, Collado MV, Sarano J.
    Medicina (B Aires); 2018 Dec 15; 78(5):329-335. PubMed ID: 30285925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.